CAMK2G and depressive symptom measurement: To investigate whether CaMKII activation is associated with cognitive decline and depression‐/anxiety‐like behaviors after SCI, we compared the expression of pCaMKII in neurons of the mPFC at various post‐SCI time points using immunohistochemical staining.